HopeStage
Back to all studies
RecruitingNCT07300956

Methylphenidate and guanfacine for ADHD in preschool children

About this titleRead the official source — NCT07300956
Medication studyAges 3–5United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 3 years to 5 years.

What will I do during this study?

After behavioural therapy, your child is randomly assigned to a clinician-prescribed guanfacine or methylphenidate treatment. The child’s clinician determines the form and dose. Caregivers and, when applicable, teachers complete study surveys; the registry does not specify the treatment period in the fields reviewed.

Listed locations
Palo Alto and 4 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: February 16, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
370
Sponsor
Children's Hospital Medical Center, Cincinnati
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 3 Years to 5 Years
Official registry ID
NCT07300956
Official title
Show the full official title

Comparing Medication Treatments for Neurodevelopmental Differences in Young Children on Rates of Beneficial Response

Recruitment & locations

Currently recruiting

Palo Alto · Boston · Kansas City

2 more locations
  • Cincinnati
  • Philadelphia

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Children's Hospital Medical Center, Cincinnati, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including Guanfacine (GUA) and Methylphenidate (MPH).

Who can participate?

Listed age limits: 3 years to 5 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies